Article info

Download PDFPDF

Study protocol for the MEXiletine hydrochloride administration trial: a placebo-controlled, randomised, double-blind, multicentre, crossover study of its efficacy and safety in spinal and bulbar muscular atrophy (MEXPRESS)

Authors

  1. Correspondence to Professor Masahisa Katsuno; ka2no{at}med.nagoya-u.ac.jp
View Full Text

Citation

Yamada S, Hashizume A, Hijikata Y, et al
Study protocol for the MEXiletine hydrochloride administration trial: a placebo-controlled, randomised, double-blind, multicentre, crossover study of its efficacy and safety in spinal and bulbar muscular atrophy (MEXPRESS)

Publication history

  • Received March 19, 2018
  • Revised August 8, 2018
  • Accepted August 9, 2018
  • First published September 11, 2018.
Online issue publication 
January 10, 2022

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.